Stem Cells in Spinal Cord Injury

Inclusion Criteria: * Age range: 18 - 65 years * Complete (AIS grade A) or incomplete (AIS grade B or C) TSCI (ISNCSCI-assessed) at time of randomization * Randomization can be done within 6-10 weeks after the TSCI incident * Level of injury between C4 to T12 * Voluntary signed informed consent by patients and Investigator before any trial-related procedures are performed Exclusion Criteria: * SCI AIS grade D or E at the start of enrolment * Level of SCI above C4 or below T12 * Positive HIV, hepatitis B or C serology * Positive Lues test * Total Nuclear Cell (TNC) count \< 1x109 TNC * Cancer, brain injury, disturbed consciousness, signs/symptoms of neurodegenerative disorder (e.g. stroke, amyotrophic lateral sclerosis, multiple sclerosis etc), diabetes mellitus type 1, renal or cardiac insufficiency based on anamnesis history and at the investigator's discretion * Patients suffering from respiratory issues that cannot breathe on their own 24/7 * Any concomitant treatment or medication that interferes with the conduct of the trial, such as immune-suppressive medication or other medication (especially methotrexate, cyclosporine, and corticosteroids have to be avoided) known to interact with the anti- inflammatory and immune-modulative actions of stem cells (non-steroid anti- inflammatory drugs (NSAIDs) are allowed) * Abuse of alcohol (daily consumption of more than 2 units of alcohol containing drinks) or illicit drugs (e.g. heroin, cocaine, XTC) * Individuals that belong to…